UK markets closed

Tyra Biosciences, Inc. (TYRA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.95+0.10 (+0.56%)
As of 09:41AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
62,518
62,518
43,008
20,636
7,203
Selling general and administrative
17,427
17,427
15,919
5,652
2,094
Total operating expenses
79,945
79,945
58,927
26,288
9,297
Operating income or loss
-79,945
-79,945
-58,927
-26,288
-9,297
Interest expense
-
-
-
-
1
Total other income/expenses net
-39
-39
-50
-19
-38
Income before tax
-69,134
-69,134
-55,325
-26,294
-9,336
Income from continuing operations
-69,134
-69,134
-55,325
-26,294
-9,336
Net income
-69,134
-69,134
-55,325
-26,294
-9,336
Net income available to common shareholders
-69,134
-69,134
-55,325
-26,294
-9,336
Basic EPS
-1.39
-
-1.32
-1.91
-0.42
Diluted EPS
-1.39
-
-1.32
-1.91
-0.42
Basic average shares
42,515
-
41,884
13,781
22,479
Diluted average shares
42,515
-
41,884
13,781
22,479